medCPU Closes $35 Million to Expand its Innovative Clinical Decision Support Technology
Date: Friday , March 04, 2016
Medical decision support startup, medCPU picks up $35 million from UPMC Enterprises with the participation from previous investor Merck Global Health Innovation Fund. This is one of the largest financing rounds closed by an Israeli medical startup this year. The new funding will help medCPU to expand its domain in New York.
Commenting on this occasion, Tal Heppenstall, President of UPMC Enterprises, says, \"Our partnership with medCPU will provide UPMC with technology and solutions that will be immediately valuable to our clinicians and patients. medCPU is a perfect example of the kind of technological innovation nurtured by UPMC Enterprises to help us transform the delivery of care, not only at UPMC but around the world\".
Sonia Ben-Yehuda, President & Co-Founder, medCPU, proclaims, \"We are excited to have UPMC as a majority partner and investor. Having access to the clinical, technological and operational expertise of one of the country\'s leading integrated health care providers and insurance systems will enable medCPU to rapidly expand our current capabilities and leverage our technology to greatly impact an industry that is moving quickly to value-based care\".
Incepted in 2008 by Eyal Ephrat and Sonia, medCPU delivers real-time clinical care advice through its Advisor Button technology for hospitals in the U.S. Through its revolutionary seamless technology, medCPU\'s solution addresses the healthcare IT challenges of interoperability, capturing all relevant patient data, and understanding free text, dictation, and structured data from electronic medical records (EMR) and ancillary systems.
medCPU now boasts of having more than 60 hospital facilities as its clients and is planning to open office in Pittsburgh. For this, the company will hire more than 20 engineers and other staff to work with UPMC to co-develop additional products and to enhance its existing solutions.